Oncolytics Biotech Inc: announces updates to intellectual property portfolio

What happened On Oct 12, 2026, Oncolytics Biotech Inc. issued a press release announcing certain updates relating to its intellectual property portfolio and ongoing efforts to extend patent protection for pelareorep as part of the Company’s long-term value creation and development strategy. The 8-K reports this under Item 8.01 (Other events).

Key details

• Filing date: Oct 12, 2026.
• Item reported: 8.01 (Other events).
• Subject: updates to the Company’s intellectual property portfolio and efforts to extend patent protection for pelareorep.
• The report was signed by Kirk Look, Chief Financial Officer, on Oct 12, 2026.

Why it may matter The filing reports an Item 8.01 other event about the company’s intellectual property and patent-protection efforts for pelareorep. This filing does not explain why the insider traded or why the company acted.